Alnylam Pharma (NASDAQ: ALNY) announced the pricing of an underwritten registered public offering of 4,736,842 shares of its common stock ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE